InvestorsHub Logo
Followers 200
Posts 10576
Boards Moderated 0
Alias Born 11/29/2011

Re: stemcell post# 81390

Saturday, 03/14/2015 11:11:12 AM

Saturday, March 14, 2015 11:11:12 AM

Post# of 92705
Simple explanation why this statement was issued for $RIGH.
Listing on the QB by the new subsidiary Genius Biotech Corp.

As of yesterday, quarterly reports are being prepared by the Wells Compliance Group, an accounting and SEC reporting services firm in Santa Monica, California. These will be posted as soon as the firm has completed them.



"Are there plans to file an S-1 registration statement on OTC:QB?
If so, will Bud Genius shareholders receive a dividend?

The company has announced its plans to launch a new subsidiary, Genius Biotech Corporation, to specialize in the healthcare aspects of medical marijuana. The company plans to file an S-1 registration statement, be fully audited, fully reporting, Sarbanes-Oxley compliant, and list on the OTC:QB. BG Medical Technologies will place its medical device, treatment solutions, and product manufacturing projects into Genius Biotech Corporation as a stand-alone corporation with its own growth potential.

Please stay tuned and watch for more information."

http://bgmedtech.com/

........

"The OTCQB venture stage marketplace will serve early and developing companies not yet ready to qualify for the higher financial standards of OTCQX, but are engaged, investor-focused and want to provide transparency to their investors. To be eligible to trade on OTCQB, companies will be required to meet a new bid price test, provide additional information based upon their reporting standard (SEC Reporting, Bank Reporting or International Reporting), and submit an annual OTCQB Certification signed by the company CEO or CFO."

http://www.otcmarkets.com/services/companies/otcqb/requirements

Page 11, para 1.3: "SEC Reporting
Companies. If the Company is not a bank and has a class of securities registered with the SEC, the Company must have filed all reports required to be filed on EDGAR. Audited Annual Financial Statements must be prepared in accordance with U.S. GAAP and contain an audit opinion that is not adverse, disclaimed, or qualified."

http://www.otcmarkets.com/content/doc/otcqb/standards.pdf